The global bioinformatics services market size was valued at USD 3.29 billion in 2025 and is projected to grow from USD 3.77 billion in 2026 to USD 11.15 billion by 2034, registering a CAGR of 14.52% during the forecast period (2026–2034). North America dominated the bioinformatics services market with a market share of 45.76% in 2025.
Bioinformatics services are specialized computational solutions used to analyze, interpret, and manage biological data generated from genomics, proteomics, and molecular research. These services support drug discovery, precision medicine, biomarker identification, and clinical research by enabling efficient processing of complex biological datasets.
The bioinformatics services market demand is driven by the growing adoption of next-generation sequencing, the rising focus on personalized medicine, and the expansion of genomic research activities. Healthcare and life science organizations are adopting these services to accelerate discoveries and improve research outcomes. Advancements in artificial intelligence, cloud-based platforms, and increasing healthcare investments are also contributing to bioinformatics services market growth.
Download a Free Sample To learn more about this report,
The bioinformatics services market has limited exposure to supply chain disruptions, as its operations are primarily driven by digital infrastructure, computational platforms, and skilled expertise rather than physical product dependencies. Supply chain disruptions have influenced the market ecosystem by affecting the availability of sequencing-related inputs, laboratory resources, cloud computing infrastructure, and technology services required for large-scale biological data analysis. The market is witnessing an S-shaped recovery, with gradual stabilization followed by accelerated adoption as healthcare organizations improve infrastructure resilience, expand bioinformatics capabilities, and integrate advanced analytics solutions.
AI-driven Bioinformatics Platforms Enhancing Automated Biological Data Interpretation
The bioinformatics services market is witnessing increasing adoption of AI-powered analytical platforms that transform complex genomic and molecular datasets into actionable insights. This shift is enabling faster data processing, improved prediction accuracy, and enhanced decision-making in drug discovery and precision medicine.
Expansion of Cloud-based Bioinformatics Services for Scalable Genomic Research
The bioinformatics services market is experiencing growing demand for cloud-based solutions that provide flexible, scalable, and cost-effective management of high-volume biological data. This transition allows pharmaceutical companies, academic institutions, and healthcare providers to access advanced computational resources without maintaining extensive in-house infrastructure. For example, DNAnexus offers cloud-based genomic data analysis platforms that support collaborative research and large-scale sequencing projects.
The bioinformatics services market forecasts investments directed toward AI-powered bioinformatics platforms, multi-omics data analytics, cloud-based genomic data management, and scalable computational infrastructure to support precision medicine, drug discovery, and clinical genomics workflows.
Key Investment and Funding Activities in Bioinformatics Services Market, 2025–2026
Innovaccer Inc.
USD 275 Million (Series F)
In January 2025, Innovaccer received funding to expand AI-powered healthcare data analytics, interoperability, and clinical informatics platforms that rely heavily on bioinformatics and biomedical data analysis.
BridGene Biosciences
USD 28 Million Series B+
In October 2025, BridGene Biosciences received funding to expand its AI-enabled drug discovery platform, computational biology capabilities, and target identification technologies.
Prenosis
USD 20 million Series A + USD 20 million BARDA contract
In January 2026, Prenosis received funding to support AI-driven biological data analysis, algorithm development, and clinical informatics for diagnostics.
Increasing Public & Private Investments in Genomics Research and Rising Outsourcing of Bioinformatics Analysis Drives Market
Growing investments by governments, research organizations, and private companies in genomics and life sciences research are driving demand for bioinformatics services. Large-scale research programs generate extensive biological datasets that require specialized computational analysis, storage, and interpretation. This has increased the adoption of outsourced bioinformatics services among academic institutions, biotechnology firms, and pharmaceutical companies seeking scalable analytical capabilities.
The increasing tendency of pharmaceutical and biotechnology companies to outsource bioinformatics analysis is driving demand for specialized service providers. Outsourcing enables organizations to access advanced computational expertise, reduce infrastructure costs, and accelerate research timelines without maintaining large in-house bioinformatics teams. This approach supports applications including target identification, clinical genomics, biomarker analysis, and regulatory data management while improving operational efficiency.
Shortage of Skilled Bioinformatics Professionals and Stringent Reimbursement Restrain Market Expansion
Bioinformatics services require expertise in computational biology, genomics, artificial intelligence, and data science, but the availability of qualified professionals remains limited. The shortage of skilled talent affects project execution, increases labor costs, and restricts the ability of service providers to scale operations. As a result, workforce constraints continue to restrain the growth of the bioinformatics services market.
The increasing use of genomic, clinical, and patient health data requires bioinformatics service providers to comply with stringent data privacy and cybersecurity regulations across different regions. Varying regulatory frameworks, complex consent requirements, and restrictions on cross-border data transfers increase compliance costs and delay collaborative research projects.
Increasing Adoption of Bioinformatics in Agricultural Genomics and Expansion of Companion Diagnostics Development Offer Growth Opportunities to Market Players
The growing application of bioinformatics in agricultural genomics is creating new opportunities for service providers beyond human healthcare. Seed companies, agricultural biotechnology firms, and research institutes are utilizing bioinformatics to identify desirable genetic traits, improve crop breeding, and enhance disease resistance. Companies such as Corteva Agriscience and Bayer Crop Science increasingly rely on genomic analytics to support crop improvement programs. As sustainable agriculture and food security become global priorities, bioinformatics service providers are expected to expand their presence in the agricultural biotechnology sector.
The rising development of companion diagnostics is creating new opportunities for bioinformatics service providers supporting molecular diagnostics companies and pharmaceutical manufacturers. Bioinformatics plays a critical role in biomarker discovery, genomic variant interpretation, and patient stratification required for targeted therapies. As regulatory approvals for precision therapies increase, the need for robust bioinformatics services is expected to expand globally.
Lack of Standardization Across Bioinformatics Pipelines and Integration of Diverse Biological Datasets Challenges Market Growth
The absence of standardized bioinformatics workflows, data formats, and analytical methodologies creates inconsistencies in genomic data interpretation across laboratories and service providers. This affects the reproducibility and comparability of research findings, making it difficult for pharmaceutical companies and healthcare organizations to integrate results from multiple sources.
Combining genomic, proteomic, transcriptomic, metabolomic, and clinical datasets into a unified analytical framework remains a significant challenge for bioinformatics service providers. Differences in data quality, formats, and interoperability increase computational complexity and delay meaningful insights.
The next-generation sequencing segment accounted for a share of 35.21% in 2025, as falling sequencing costs and expanding clinical genomics programs increased biological data generation. High-throughput sequencing workflows further strengthened demand for specialized bioinformatics analysis and interpretation.
The scientific software testing segment is expected to grow at a CAGR of around 15.03% during the forecast period due to increasing validation requirements for bioinformatics software. Rising adoption of AI-based analytical platforms further drives demand for independent testing services.
Request Customizationto receive a tailored report.
The drug discovery segment accounted for a share of 25.07% in 2025 due to increasing computational target identification and expanding virtual screening applications, accelerating pharmaceutical research and candidate selection.
The drug discovery segment is expected to grow at a CAGR of 25.07% during the forecast period, driven by rising AI-enabled molecule discovery and increasing multi-omics integration. Predictive bioinformatics models further improve lead optimization efficiency.
By end-use industry, academics accounted for a share of 37.15% in 2025 due to growing genomics research funding and expanding university sequencing projects. Increasing access to public genomic databases further supports bioinformatics service adoption.
The animal segment is expected to grow at a CAGR of 15.86% during the forecast period, driven by expanding livestock genomics and veterinary genetic research. Increasing disease surveillance programs further accelerates bioinformatics adoption in animal health.
Speak to an Analystto discuss market opportunities.
North America: Market Dominance Led by Strong Genomics Research Ecosystem and High Adoption of Precision Medicine
The North America bioinformatics services market accounted for the largest regional share of 45.76% in 2025, driven by an established genomics research ecosystem, high adoption of precision medicine, and substantial investments in pharmaceutical R&D. The region benefits from the presence of leading biotechnology companies, advanced sequencing infrastructure, and extensive collaborations between academic institutions and industry.
The US bioinformatics services market was valued at USD 1.31 billion in 2025, driven by increasing investments in genomics research, expanding precision medicine initiatives, and growing demand for AI-based biological data analysis. Pharmaceutical companies, biotechnology firms, and research organizations are increasingly outsourcing bioinformatics services to accelerate drug discovery and clinical research.
The bioinformatics services market in Canada was valued at USD 195.86 million in 2025, supported by expanding government-funded genomics research, increasing collaborations between academic institutions and biotechnology companies, and rising adoption of precision healthcare. National initiatives supporting genomic medicine and personalized healthcare are increasing demand for advanced biological data analysis.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific: Fastest Growth Driven by Government-led Genomics Initiatives and Expanding Regional Bioeconomy
The Asia Pacific bioinformatics services market is expected to grow at a CAGR of 16.43% during the forecast period, showcasing the fastest regional growth. Growth is supported by government investments in genomics, rapid expansion of biotechnology clusters, and increasing pharmaceutical outsourcing to the region. According to the World Health Organization, the Asia Pacific region accounts for nearly 60% of the global population, creating one of the world's largest genomic research opportunities and accelerating demand for bioinformatics services.
The China bioinformatics services market was valued at USD 187.19 million in 2025, supported by the expansion of domestic sequencing companies and increasing AI integration into life sciences research. China's 14th Five-Year Plan identifies biotechnology as a strategic emerging industry, accelerating investments in genomics and computational biology infrastructure.
The India bioinformatics services market was valued at USD 93.90 million in 2025, fueled by its globally competitive contract research ecosystem, abundant bioinformatics talent, and expanding digital health infrastructure. According to the Department of Biotechnology (DBT), Government of India, the GenomeIndia Project aims to sequence 10,000 Indian genomes, significantly increasing demand for bioinformatics analysis.
The Japan bioinformatics services market was valued at USD 111.29 million in 2025, supported by increasing adoption of precision oncology and robust academia-industry collaborations. The country emphasizes integrating genomic information into routine healthcare while supporting translational medicine research. According to Japan's Ministry of Health, Labour and Welfare, people aged 65 years and above account for approximately 30% of the population, increasing demand for genomics-driven disease research and bioinformatics services.
The bioinformatics services market competitive landscape is moderately fragmented, with competition driven by global bioinformatics providers, genomics companies, contract research organizations, and specialized analytics firms. Leading players compete through advanced computational platforms, AI-enabled data analysis, cloud-based bioinformatics solutions, domain expertise, and strategic collaborations with pharmaceutical and biotechnology companies. Emerging firms focus on niche multi-omics capabilities and customized analytical services.
June 2026: Illumina, Inc. launched StrataMap Spatial Solution, an end-to-end spatial transcriptomics research platform.
May 2026: QIAGEN Digital Insights announced a collaboration with NVIDIA to integrate the NVIDIA BioNeMo platform.
November 2025: EpiCypher launched CUTANA Cloud, a cloud-based epigenomics data analysis platform powered by DNAnexus.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.
Asia Pacific TB Diagnostics Market Size, Share & Growth Graph by 2034
LAMEA Tangential Flow Filtration Market Size Analysis and Forecast 2034
North America TB Diagnostics Market Size & Trends Analysis by 2034
Europe TB Diagnostics Market Growth Trends and Competitive Analysis 2034
North America Tangential Flow Filtration Market Size, Share and Forecast to 2034
Asia Pacific Tangential Flow Filtration Market Size, Share & Trends | Industry Report, 2033
We are featured on:
sales@straitsresearch.com